The continuum of ovarian response leading to BIRTH, a real world study of ART in Spain

The continuum of ovarian response leading to BIRTH, a real world study of ART in Spain

Abstract Background The first biosimilar of recombinant follicle stimulating hormone (rFSH) launched in Europe was Bemfola® in 2014 following a clinical development programme demonstrating efficacy and safety to the satisfaction of the European Medicines Agency. Since then the increasing use of bios...

Full description

Bibliographic Details
Main Authors: Marcos Ferrando, Buenaventura Coroleu, Luis Rodríguez-Tabernero, Gorka Barrenetxea, Cristina Guix, Fernando Sánchez, Julian Jenkins, on behalf of the BIRTH study group
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Fertility Research and Practice
Subjects:
IVF
Biosimilar
FSH
Real world study
Combination protocols
Follitropin CRS
Online Access:http://link.springer.com/article/10.1186/s40738-020-00081-4

Internet

http://link.springer.com/article/10.1186/s40738-020-00081-4

Similar Items